Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US9567363 | OTSUKA | Certain compounds, compositions and methods |
Oct, 2028
(4 years from now) | |
US8268800 | OTSUKA | Certain compounds, compositions and methods |
Aug, 2030
(6 years from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8618075 | OTSUKA | Certain compounds, compositions and methods |
Oct, 2028
(4 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Chemical Entity Exclusivity(NCE) | Jul 07, 2025 |
Orphan Drug Exclusivity(ODE-316) | Jul 07, 2027 |
NCE-1 date: 07 July, 2024
Market Authorisation Date: 07 July, 2020
Treatment: Method for inhibiting degradation of a cda substrate by administering cedazuridine
Dosage: TABLET;ORAL